Cancer

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

First-in-class catheter-based sensing technology designed to sense neuronal signals that indicate pain or disease and destroy those nerves at the…

1 year ago

Theriva™ Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer

ROCKVILLE, Md., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed…

1 year ago

TScan Therapeutics Named a Top Place to Work by The Boston Globe for Three Consecutive Years

WALTHAM, Mass., Dec. 05, 2024 (GLOBE NEWSWIRE) --  TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the…

1 year ago

RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System

Over Ten Medical Institutions Nationwide have Initiated RenovoCath Purchase Process, Further Accelerating Commercialization Strategy RenovoRx Estimates Initial Target Market Size…

1 year ago

Medicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 and KEYTRUDA® (pembrolizumab) Combination Dose Escalation Arm of the ABILITY-1 Study

70-year-old patient with advanced chemo-refractory anal cancer achieves complete response (CR) in 8 weeks when treated with MDNA11 in combination…

1 year ago

Outcomes4Me and CURE® Media Group Partner to Accelerate Patient Access to Innovative Cancer Therapies

Exclusive collaboration empowers patients with cancer through access to evidence-based and informative resources that provide guidance at every stage of…

1 year ago

Up to $1.6 Million in Funding Available for NSF Tissue Engineering Research Utilizing the ISS National Lab

Solicitation now open for multiple awards supporting space-based tissue engineering and mechanobiology research KENNEDY SPACE CENTER, Fla., Dec. 4, 2024…

1 year ago

New Study Indicates SpotitEarly Detects Multiple Cancers Early By Using AI, Trained Canines And Breath Samples

Innovative platform can identify breast, lung, prostate and colorectal cancers with a single, non-invasive test ENGLEWOOD, N.J., Dec. 4, 2024…

1 year ago

Cleerly Raises $106 Million in Funding Led by Insight Partners to Revolutionize Heart Disease Care

DENVER, Dec. 4, 2024 /PRNewswire/ -- Today Cleerly, a leader in advanced cardiovascular imaging, announced the successful closure of its Series…

1 year ago

Study published in the New England Journal of Medicine AI Concludes that the Sepsis ImmunoScore™, the First FDA-Authorized AI Tool for Sepsis, has both significant Diagnostic and Predictive Power

Groundbreaking NEJM AI Study Highlights the Ability of Prenosis' Sepsis ImmunoScore™ to Holistically Predict Adverse Outcomes, Ushering in a New…

1 year ago